Skip to Content

Venexa Tablets

Generic Name: multivitamin
Dosage Form: tablet

Medically reviewed by Drugs.com. Last updated on Jan 1, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

DESCRIPTION:

Each caplet contains:

Vitamin A (as retinyl acetate)………………………….. 1500 mcg
Vitamin C (as ascorbic acid)……………………………… 120 mg
Vitamin D3 (as cholecalciferol)…………………………… 20 mcg
Vitamin E (dl-alpha tocopheryl acetate)…………………… 30 mg
Thiamin (as thiamine mononitrate)………………………… 3 mg
Riboflavin (vitamin B2)……………………………………. 3.4 mg
Niacin (as niacinamide)…………………………………… 20 mg
Vitamin B6 (as pyridoxine hydrochloride)…………………. 20 mg
Folate (as folic acid)……….. 1700 mcg DFE (1000 mcg folic acid)
Vitamin B12 (as cyanocobalamin)………………………….. 8 mcg
Calcium (as calcium carbonate)…………………………. 200 mg
Magnesium (as magnesium oxide)……………………… 200 mg
Zinc (as zinc oxide)……………………………………….. 25 mg
Selenium (as selenium amino acid chelate)………………. 55 mcg
Manganese (as manganese sulfate)……………………… 2.3 mg
Chromium (as chromium polynicotinate)……………….. 35 mcg
Molybdenum (as molybdenum amino acid chelate)……… 45 mcg

Other Ingredients:
Organic cocoa powder, croscarmellose sodium, crospovidone, magnesium stearate,
microcrystalline cellulose, silicon dioxide, stearic acid. Clear coating: (hydroxypropyl
methylcellulose, PEG-8).

INDICATIONS:

Venexa is indicated to provide vitamin supplements to men and women. Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.

CONTRAINDICATIONS:

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING:

Administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient.

PRECAUTIONS:

Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that
hematologic remission can occur while neurological manifestations remain
progressive.
There is a potential danger in administering folic acid to patients with undiagnosed
anemia, since folic acid may obscure the diagnosis of pernicious anemia by
alleviating the hematologic manifestations of the disease while allowing the
neurologic complications to progress. This may result in severe nervous system
damage before the correct diagnosis is made. Adequate doses of vitamin B12 may
prevent, halt, or improve the neurologic changes caused by pernicious anemia.
The patient’s medical conditions and consumption of other drugs, herbs, and/or
supplements should be considered.

For use on the order of a healthcare practitioner.
Call your doctor about side effects. To report side effects, call PureTek Corporation
at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Drug Interactions:

Venexa is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin or Clopidogrel).

Adverse Reactions:

Allergic sensitization has been reported following both oral and parenteral
administration of folic acid.
Adverse reactions have been reported with specific vitamins and minerals but
generally at levels substantially higher than those contained herein. However,
allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the
usual recommended levels, has been associated with gastrointestinal intolerance in
some patients.

DOSAGE AND ADMINISTRATION:

One (1) Venexa caplet daily, between meals or as directed by a physician. Do not administer to children under the age of 12.

HOW SUPPLIED:

Venexa are beige speckled, oblong, coated caplets in bottles containing 30 caplets – NDC 59088-176-54. Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure. Store at controlled room temperature 20° to 25°C (68° to 77°F). [See USP]. Protect from light and moisture and avoid excessive heat.

Storage

Do not use if bottle seal is broken.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Store at controlled room temperature 20º-25ºC (68º-77ºF). [See USP].
Protect from light and moisture and avoid excessive heat.
To report a serious adverse event or to obtain product information, contact
877-921-7873.

Venexa

Manufactured in the USA by:

PureTek Corporation
Panorama City, CA 91402
Questions? Call toll-free:
1-877-921-7873

VENEXA
folic acid tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:59088-176
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
.ALPHA.-TOCOPHEROL ACETATE, DL- (.ALPHA.-TOCOPHEROL, DL-) .ALPHA.-TOCOPHEROL, DL- 30 mg
MAGNESIUM OXIDE (MAGNESIUM CATION) MAGNESIUM OXIDE 200 mg
CHROMIUM NICOTINATE (CHROMIC CATION) CHROMIUM NICOTINATE 35 ug
PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE) PYRIDOXINE 20 mg
MOLYBDENUM (MOLYBDENUM) MOLYBDENUM 45 ug
SELENIUM (SELENIUM) SELENIUM 55 ug
CHOLECALCIFEROL (CHOLECALCIFEROL) CHOLECALCIFEROL 20 ug
RIBOFLAVIN (RIBOFLAVIN) RIBOFLAVIN 3.4 mg
NIACINAMIDE (NIACINAMIDE) NIACINAMIDE 20 mg
ASCORBIC ACID (ASCORBIC ACID) ASCORBIC ACID 120 mg
FOLIC ACID (FOLIC ACID) FOLIC ACID 1000 ug
CYANOCOBALAMIN (CYANOCOBALAMIN) CYANOCOBALAMIN 8 ug
CALCIUM CARBONATE (CALCIUM CATION) CALCIUM CATION 200 mg
VITAMIN A ACETATE (VITAMIN A) VITAMIN A 1500 ug
THIAMINE MONONITRATE (THIAMINE ION) THIAMINE 3 mg
ZINC OXIDE (ZINC CATION) ZINC CATION 25 mg
MANGANESE SULFATE (MANGANESE CATION (2+)) MANGANESE CATION (2+) 2.3 mg
Inactive Ingredients
Ingredient Name Strength
POLYETHYLENE GLYCOL 400
COCOA
CROSPOVIDONE
STEARIC ACID
MICROCRYSTALLINE CELLULOSE
CROSCARMELLOSE SODIUM
SILICON DIOXIDE
MAGNESIUM STEARATE
Product Characteristics
Color yellow (Yellow to Brown speckled caplet) Score no score
Shape CAPSULE Size 19mm
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description
1 NDC:59088-176-54 30 TABLET in 1 BOTTLE, PLASTIC
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 01/29/2021
Labeler - PureTek Corporation (785961046)
PureTek Corporation

Frequently asked questions